Nexium, Prilosec, and Prevacid

Proton pump inhibitors Nexium, Prolsec, and Prevacid have been linked to a significant increase in the risk of kidney failure, chronic kidney disease, acute renal failure, interstitial nephritis, and other kidney injury.

These heartburn drugs are available over the counter (OTC) or by prescription.  Proton pump inhibitors (PPIs) decrease the amount of acid in the stomach to treat heartburn and gastroesophageal reflux disease.

Proton pump inhibitor heartburn medications like Nexium, Prilosec, and Prevacid increase their risk of kidney disease by 20-percent to 50-percent

A study published in January 2016 by JAMA Internal Medicine found that Nexium, Prilosec, and Prevacid can increase the risk of developing chronic kidney disease as much as 50 percent.  As of 2013, approximately 15 million American used these heartburn drugs.  Researchers have also found that as many as 25 percent of people who use nexium, prilosec, or prevacid on a regular basis could discontinue use without increased symptoms of heartburn.

A previous study published in CMAJ Open had concluded that PPIs Nexium, Prilosec, and Preacid triple the risk of interstitial nephritis.  Interstitial nephritis is a kidney disorder in which the spaces between the kidney tubules are inflamed.  This can cause problems with the way your kidneys work leading to mild to severe kidney problems, including acute renal failure.

In December 2014, the FDA added a warning for acute interstitial nephritis to the Nexium, Prilosec, and Prevacid labels.

People who suffered kidney problems after taking PPIs like Nexium, Prilosec, or Prevacid may be entitled to compensation

If you or someone you know has experienced kidney failure, chronic kidney disease, acute renal failure, interstitial nephritis, and other kidney injury while or after taking Nexium, Prilosec, or Prevacid, contact our office online or call 404-554-0777 today.